Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

OBJECTIVE: To evaluate the impact of once-weekly exenatide (EQW) on microvascular and cardiovascular (CV) outcomes by baseline renal function in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). RESEARCH DESIGN AND METHODS: Least squares mean difference (LSMD) in estimated glomerular fi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Care
Hauptverfasser: Bethel, M. Angelyn, Mentz, Robert J., Merrill, Peter, Buse, John B., Chan, Juliana C., Goodman, Shaun G., Iqbal, Nayyar, Jakuboniene, Neli, Katona, Brian, Lokhnygina, Yuliya, Lopes, Renato D., Maggioni, Aldo P., Ohman, Peter, Tankova, Tsvetalina, Bakris, George L., Hernandez, Adrian F., Holman, Rury R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Diabetes Association 2020
Schlagworte:
Cardiovascular and Metabolic Risk
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7411285/
https://ncbi.nlm.nih.gov/pubmed/31757838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1065
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge